| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |